PLoS ONE (Jan 2021)

Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.

  • Philip G Ferstl,
  • Natalie Filmann,
  • Eva-Maria Heilgenthal,
  • Andreas A Schnitzbauer,
  • Wolf O Bechstein,
  • Volkhard A J Kempf,
  • David Villinger,
  • Tilman G Schultze,
  • Michael Hogardt,
  • Christoph Stephan,
  • Haitham Mutlak,
  • Nina Weiler,
  • Marcus M Mücke,
  • Jonel Trebicka,
  • Stefan Zeuzem,
  • Oliver Waidmann,
  • Martin-Walter Welker

DOI
https://doi.org/10.1371/journal.pone.0245091
Journal volume & issue
Vol. 16, no. 1
p. e0245091

Abstract

Read online

ObjectivesRising prevalence of multidrug-resistant organisms (MDRO) is a major health problem in patients with liver cirrhosis. The impact of MDRO colonization in liver transplantation (LT) candidates and recipients on mortality has not been determined in detail.MethodsPatients consecutively evaluated and listed for LT in a tertiary German liver transplant center from 2008 to 2018 underwent screening for MDRO colonization including methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant gram-negative bacteria (MDRGN), and vancomycin-resistant enterococci (VRE). MDRO colonization and infection status were obtained at LT evaluation, planned and unplanned hospitalization, three months upon graft allocation, or at last follow-up on the waiting list.ResultsIn total, 351 patients were listed for LT, of whom 164 (47%) underwent LT after a median of 249 (range 0-1662) days. Incidence of MDRO colonization increased during waiting time for LT, and MRDO colonization was associated with increased mortality on the waiting list (HR = 2.57, pConclusionsColonization with MDRO is associated with increased mortality on the waiting list, but not in short-term follow-up after LT. Moreover, colonization with CRGN seems associated with high mortality in liver transplant candidates and recipients.